# OnCo record infusion-reaction-management (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/infusion-reaction-management/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "infusion-reaction-management" ;
  schema:name "Infusion and hypersensitivity reactions during anticancer treatment: recognition, emergency treatment and rechallenge"@en ;
  schema:alternateName "infusion reaction"@en, "infusion-related reaction"@en, "hypersensitivity reaction to chemotherapy"@en, "anaphylaxis in the chemotherapy unit"@en, "chemotherapy allergic reaction"@en, "taxane reaction"@en, "platinum allergy"@en, "rituximab infusion reaction"@en, "rechallenge after infusion reaction"@en ;
  schema:description "Some cancer drugs can cause a reaction while they go in: flushing, itching, a rash, chills, tightness in the chest or throat, or feeling faint. Tell the nurse at once. They will stop the drip and check you; most reactions are mild and settle, and many people can then carry on more slowly. A severe allergic reaction (anaphylaxis) is treated at once with an adrenaline injection into the thigh."@en ;
  schema:url <https://onco.cc/protocols/infusion-reaction-management/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:related <https://onco.cc/protocols/sact-administration-checks-at-the-chair/>, <https://onco.cc/protocols/premedication-before-reaction-prone-anticancer-drugs/> ;
  onco:drugs <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/asparaginase/>, <https://onco.cc/drugs/pegylated-liposomal-doxorubicin/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/daratumumab/> ;
  onco:terms <https://onco.cc/terms/extravasation-infusion-reaction/>, <https://onco.cc/terms/crs/> .
